Abstracts (HTML) List of Authors

Abdullah, Zeinab

Impaired liver regeneration in obesity is driven by IFNAR signaling in Kupffer cells

Abou-Alfa, Ghassan K.

Five-year overall survival (OS) and OS by tumour response measures from the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC)

Adami, Elenora

Single-nuclei RNA-sequencing of human liver samples reveals heterogeneity and compositional changes of biliary epithelial cell subpopulations during the progression of primary sclerosing cholangitis

Adao, Irina

Exploring the Role of Social Determinants of Health in autoimmune liver disease – a pilot study within the European Reference Network on hepatological diseases

Adenugba, Akinbami

Soluble CD46 as a diagnostic biomarker for steatotic liver disease

Adlung, Lorenz

New treatment targets in autoimmune hepatitis: detection using integrative omics and target validation in a proof of concept phase II clinical trial

Agelopoulos, Konstantin

Multimodal assessment of the skin-nerve-axis identifies specific patterns in patients with cholestatic liver disease-associated pruritus

Aguilar, Ferran

Kurzfristige Mortalität und Diagnose von ACLF wird durch TIPS bei hydropischer Dekompensation aufgehoben: Eine Fall-Kontroll-Studie

Ahmad, Husna

Molecular Insights: Gene Expression in HCC and Testicular Cancer among ALD Patients
Role of SOCS2 in Chemokine Signalling and its Impact on Hepatocellular Carcinoma Cells

Aicher, David

A 5:2 intermittent fasting regimen ameliorates MASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

Aichner, Elisabeth

Patient safety, trans-sectoral quality of care, cost efficiency and interprofessional competence: An analysis of the interprofessional training wards A-STAR in comparison to conventional wards with a hepatological focus at Regensburg University Hospital

Aigner, Elmar

Unique histological liver phenotype in children and adults with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype)
Interaktion zwischen metabolischen Faktoren und Genetik am Beispiel Alpha-1-Antitrypsin-Mangel

Akarca, Ayse U.

Characterization of T cell subsets and dynamic remodeling following immune checkpoint inhibition in hepatocellular carcinoma

Akhtar, Tasleem

Amelioration of dyslipidemia and hepatic fibrosis by quercetin in comparison with silymarin

Ala, Aftab

Interaktion zwischen metabolischen Faktoren und Genetik am Beispiel Alpha-1-Antitrypsin-Mangel

Albadry, Mohamed

Cellular cytokinesis, hyperplasia and hypertrophy define critical phases for liver regeneration efficiency

Al-Batran, Salah-Eddin

CLEAN-DUCT / TRITICC-3 (IKF070) – A Phase IIa, Prospective, Single-Arm, Open-Label, Non-Randomized, Multi-Center Pilot Study of Durvalumab+Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma

Albert, Andreas

Impact of Additive Chemotherapy on Survival in Stage IV Colon Cancer Patients Following Liver Metastasectomy: A Retrospective Analysis with a Focus on Chemotherapy Regime Efficacy
How physical activity affects quality of life in patients with UICC IV hepatobiliary and gastrointestinal cancer undergoing systemic therapy
Digital single-operator cholangioscopy characterizes distinct phenotypes of primary sclerosing cholangitis

Albin, Jan Einar

Cell type specific decoding of TGF-β2 production, signaling and outcome in the dynamics of cholestatic liver disease

Alcazar, Milena

Mobile Ultrasound Screening Program for MASLD in High Cardiovascular Risk Communities in Rural Colombia: Initial Results

Aleman, Soo

Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48 weeks of bulevirtide monotherapy

Alex, Sophie

Linker Phosphorylation of Smad3 as a Driver of Cholangiocarcinoma Progression and Chemotherapy Resistance

Algül, Hana

Spontaneous HCC development in mice expressing all HBV transcripts is STAT3 dependent and indicates an oncogenic effect of HBx

Ali, Adnan

A 5:2 intermittent fasting regimen ameliorates MASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

Ali, Arslan

Proteomic profiling of FFPE liver specimens of biliary atresia patients

Ali Mughal, Neelam

Amelioration of dyslipidemia and hepatic fibrosis by quercetin in comparison with silymarin

Alizei, Elahe Salimi

Skewed HBV-specific CD8+T cell repertoire in chronic versus acute-resolving HBV infection

Alkhouri, Naim

Liver enzymes reductions from baseline over time in resmetirom treated patients in a Phase 3 study, MAESTRO-NASH

Allescher, Lea

A Biliary Organoid Approach to Study the Transition from Primary Sclerosing Cholangitis to Cholangiocarcinoma

Allgeier, Julian

Improved Mortality Risk Stratification in Decompensated Liver Cirrhosis and Acute-On-Chronic Liver Failure Using the Updated KDIGO AKI Criteria
Effects of sodium-linked glucose transporter 2 inhibitors in liver transplant recipients with impaired renal function

Allweiss, Lena

Analysis of the CXCL9-11 mediating recruitment of CXCR3+CD4 T cells to HDV-infected livers
Bulevirtide in combination with pegylated interferon alfa-2a shows a sustained off-treatment response in the liver

Almeida, Gustavo

Circulating CD8 T cells are sentinels for intrahepatic T cell responses during HBV infection

Al-Shakhshir, Sarah

Safety and efficacy of Upadacitinib in patients with primary sclerosing cholangitis: a multicentre, retrospective study

Al Shonikat, Ruba

New treatment targets in autoimmune hepatitis: detection using integrative omics and target validation in a proof of concept phase II clinical trial

Altamura, Sandro

Myeloid- and hepatocyte-specific deletion of group VIA calcium-independent phospholipase A2 leads to opposing phenotypes during HFD-induced NASH

Altmann, Philipp

Feasibility and Mortality Prediction of Bedside Rectus Femoris Muscle Ultrasound for Sarcopenia Diagnosis in Liver Cirrhosis

Altomonte, Jennifer

Chimeric VSV-NDV mediates a multimechanistic therapeutic response supported by immune activation in orthotopic hepatocellular carcinoma
Immunoregulation and MDSC-Mediated T Cell Paralysis in Hepatocellular Carcinoma Following rVSV-NDV Therapy

Alunni-Fabbroni, Marianna

PD-L1 expressing circulating tumor cells to predict survival in patients with advanced hepatocellular carcinoma treated with immunotherapy: a prospective, multicenter study
Circulating tumor cells predict recurrence risk in early HCC treated with local ablative therapy
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab
Adiposity and myosteatosis are prognostic biomarkers in advanced HCC patients receiving immunotherapy
Immune Modulation in Untreated, Contralateral Hepatic Metastases after Yttrium-90 Radioembolization of Microsatellite Stable Colorectal Cancer

Ameen, Esha

Role of SOCS2 in Chemokine Signalling and its Impact on Hepatocellular Carcinoma Cells

Ameis, Lucia

Disease stage dependent efficacy of systemic apical sodium dependent bile acid transporter (ASBT) inhibition in mice with cholemic nephropathy

Amygdalos, Iakovos

Cytokine adsorption during normothermic machine perfusion of porcine livers

Andreone, Pietro

Insufficient control of cholestatic pruritus in primary biliary cholangitis (PBC) with current therapies: baseline data from the ongoing Phase 3 GLISTEN (Global Linerixibat Itch STudy of Efficacy and safety iN PBC) trial

Angendohr, Carolin

The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD

Antoni, Christoph

Intra and Extrahepatic Cholestasis Due to Hepatic Duct Compression Caused by Cavernous Transformation of the Portal Vein: A Case Report and Literature Review
Comparative evaluation of standard machine learning models for liver fibrosis detection
Health related quality of life (HRQoL) in patients Metabolic dysfunction-associated steatotic liver disease (MASLD)

Anz, David

Adiposity and myosteatosis are prognostic biomarkers in advanced HCC patients receiving immunotherapy

Arjas, Somayeh Alinaghi

Genetic Variant Analysis in Low Phospholipid-Associated Cholelithiasis Patients through Whole Exome Sequencing

Arroyo, Vicente

Kurzfristige Mortalität und Diagnose von ACLF wird durch TIPS bei hydropischer Dekompensation aufgehoben: Eine Fall-Kontroll-Studie

Aschenbach, René

Comparative analysis of surrogate markers of intestinal permeability, bacterial translocation, and gut vascular barrier damage in cirrhosis

Aschenbrenner, Elisabeth

Targeting p53 Isoforms: A Novel Approach for Anticancer Therapy

Ashfaq, Isbah

Role of SOCS2 in Chemokine Signalling and its Impact on Hepatocellular Carcinoma Cells

Assum, Ines

Multi-Omics Gene Signatures Predict Disease Trajectory in a Cholestasis-Based ACLF Mouse Model

Ast, Volker

Cell type specific decoding of TGF-β2 production, signaling and outcome in the dynamics of cholestatic liver disease

Athanasoulas, Georgios

Acute-on-Chronic Liver Failure Triggered by Streptococcus pyogenes Superinfection from a Mosquito Bite: A Case Report
Optimizing Piperacillin/Tazobactam Dosing in ACLF Patients through Interprofessional Therapeutic Drug Monitoring

Auhuber, Carmen

Exploring the Role of Social Determinants of Health in autoimmune liver disease – a pilot study within the European Reference Network on hepatological diseases

Averhoff, Pia

CRISPR/Cas9-mediated Cxcr3 gene knock-out in unstimulated murine primary CD4+T cells
Tolerance induction by liver sinusoidal endothelial cells is preserved in liver fibrosis

Avila, Jose

A 5:2 intermittent fasting regimen ameliorates MASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

Avila, Jose Barragan

Antibiotic-mediated microbiota depletion limits IgA-related fibrogenesis in metabolic dysfunction-associated steatohepatitis